April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Comparing Significant Change in Visual Fields in Ocular Hypertensive Eyes With the Ocular Hypertension Treatment Study (OHTS) Abnormality Criteria, Guided Progression Analysis (GPA) and Visual Field Index (VFI)
Author Affiliations & Notes
  • S. Srisamran
    Ophthalmology, UCSD, Hamilton Glaucoma Center, San Diego, California
  • L. M. Alencar
    Ophthalmology, UCSD, Hamilton Glaucoma Center, San Diego, California
    Ophthalmology, University of Sao Paulo, Sao Paulo, Brazil
  • L. M. Zangwill
    Ophthalmology, UCSD, Hamilton Glaucoma Center, San Diego, California
  • C. A. Girkin
    Ophthalmology, University of Alabama, Birmingham, Alabama
  • J. M. Liebmann
    New York Eye and Ear Infirmary, New York, New York
  • C. Bowd
    Ophthalmology, UCSD, Hamilton Glaucoma Center, San Diego, California
  • F. A. Medeiros
    Ophthalmology, UCSD, Hamilton Glaucoma Center, San Diego, California
  • R. N. Weinreb
    Ophthalmology, UCSD, Hamilton Glaucoma Center, San Diego, California
  • P. A. Sample
    Ophthalmology, UCSD, Hamilton Glaucoma Center, San Diego, California
  • Footnotes
    Commercial Relationships  S. Srisamran, None; L.M. Alencar, None; L.M. Zangwill, Carl Zeiss Meditec, F; Heidelberg Engineering, F; Nidek, F; Optovue, F; C.A. Girkin, Carl Zeiss Meditec, F; Optovue, F; Heidelberg Engineering, F; J.M. Liebmann, Carl Zeiss Meditec, R; Heidelberg Engineering, R; C. Bowd, Lace Elettronica, F; F.A. Medeiros, Carl Zeiss Meditec, F; Carl Zeiss Meditec, C; Carl Zeiss Meditec, R; R.N. Weinreb, Paradigm, F; Carl Zeiss Meditec, F; Heidelberg Engineering, F; Topcon, F; Carl Zeiss Meditec, C; P.A. Sample, Carl Zeiss Meditec, F; Heidelberg Engineering, F; Welch-Allyn, F; Haag-Streit, F.
  • Footnotes
    Support  EY08208 (PAS), EY11008 (LZ), EY14267 (PAS,JL,CG), EY13959 (CAG), Eyesight Foundation (CAG), Grants for participants’ glaucoma medications: Alcon, Allergan, Pfizer, Merck, Santen
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2225. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Srisamran, L. M. Alencar, L. M. Zangwill, C. A. Girkin, J. M. Liebmann, C. Bowd, F. A. Medeiros, R. N. Weinreb, P. A. Sample; Comparing Significant Change in Visual Fields in Ocular Hypertensive Eyes With the Ocular Hypertension Treatment Study (OHTS) Abnormality Criteria, Guided Progression Analysis (GPA) and Visual Field Index (VFI). Invest. Ophthalmol. Vis. Sci. 2009;50(13):2225.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare the identification of significant change from baseline normal visual fields using OHTS abnormality criteria, GPA and VFI in ocular hypertensive eyes from Diagnostic Innovations In Glaucoma Study (DIGS) and African Descent and Glaucoma Evaluation Study (ADAGES).

Methods: : Five or more (11.2+6.4, mean+SD) reliable consecutive visual fields from 149 eyes of 77 ocular hypertension (OHT) patients were included. Patients ranged from age 19.8 to 79.9 (56.3+11.8) years and had both normal optic discs by masked stereophotograph review and two normal standard Humphrey 24-2 visual fields (VF) at baseline. Patients had either highest untreated IOP >21 on at least two occasions or were currently on IOP lowering medications. In addition, central corneal thickness (CCT) was between 475 and 650 microns (579+36). Visual field progression from normal baseline using the OHTS endpoint criteria (glaucoma hemifield test of outside normal limits or pattern standard deviation (PSD) at 5% or worse on 3 fields), GPA (likely progression) and VFI (significant slope >5%) was determined.

Results: : Twenty-nine eyes progressed by at least one algorithm. The mean follow-up duration for progressed eyes was 9.8+4.7 years and for non-progressed eyes was 8.0+4.2 years. The mean+SD baseline IOPs of thirty-eight untreated patients and thirty-nine treated patients were 25.2+2.6 and 26.5+4.2 mm Hg. Baseline mean vertical cup to disc ratio was 0.43+0.16. VF mean deviation and PSD were - 0.17+1.34 and 1.69+0.43 dB, respectively. Of these 149 eyes, VFI (n=19) showed significantly more eyes as changing than did GPA (n=11, p=0.006). Nine eyes changed using OHTS abnormality criteria. To compare the agreement among the algorithms, pair-wise Kappa analyses yielded values of 0.26+0.11, (GPA/VFI), 0.07+0.09 (OHTS/VFI) and 0.36+0.14 (OHTS/GPA) for degree of agreement.

Conclusions: : Thirteen percent of the OHT eyes in this study showed significant progression in visual fields on VFI, which called more change than did OHTS or GPA. At best, the agreement among the three algorithms was only fair suggesting caution should be used when comparing results from studies using different criteria for change in visual field status.

Keywords: visual fields • perimetry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×